Bavachalcone

• CAT Number: I002968
• CAS Number: 28448-85-3
• Molecular Formula: C20H20O4
• Molecular Weight: 324.37
• Purity: ≥95%
• Solubility: DMSO: ≥ 34 mg/mL
• Storage: Store at -20°C
• IUPAC Name: (E)-1-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
• InChI: InChI=1S/C20H20O4/c1-13(2)3-7-15-11-17(20(24)12-19(15)23)18(22)10-6-14-4-8-16(21)9-5-14/h3-6,8-12,21,23-24H,7H2,1-2H3/b10-6+
• InChIKey: BLZGPHNVMRXDCB-UXBLZVDNSA-N
• SMILES: CC(=CCC1=CC(=C(C=C1O)O)C(=O)C=CC2=CC=C(C=C2)O)C

Bavachalcone (Cat No.:I002968) is a natural compound derived from Psoralea corylifolia. It possesses diverse pharmacological properties, including anti-inflammatory, anti-cancer, antioxidant, and antimicrobial effects. Bavachalcone has demonstrated the ability to inhibit cancer cell growth, reduce inflammation, and scavenge free radicals. With its potential applications in pharmaceutical and nutraceutical research, Bavachalcone has garnered interest as a medicinal compound.

Reference

[1]. Park CK, et al. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Biochem Pharmacol. 2008 Jun 1;75(11):2175-82.
[2]. Choi YH, et al. In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia. Planta Med. 2008 Sep;74(11):1405-8.
[3]. Shan L, et al. Comparison of the Inhibitory Potential of Bavachalcone and Corylin against UDP-Glucuronosyltransferases. Evid Based Complement Alternat Med. 2014;2014:958937.